9 withdrawn. 9 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 9 | Withdrawn 9 |
Follow Conjunctivitis: new trials by email Literature Review of Conjunctivitis trials Research Report on Conjunctivitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trachoma Elimination Study by Focused Antibiotic (TESFA) Azithromycin mass treatment, Azithromycin targeted treatment - Trachoma | Phase 4 | Withdrawn | Emory University | 2025-06-01 | 2025-07-16 | |
| Azithromycin Reduction to Reach Elimination of Trachoma B Azithromycin - Trachoma | Phase 4 | Withdrawn | University of California, San Francisco | 2024-10-01 | 2026-03-13 | |
| Manuka Eye Droops for Treatment of Allergy Manuka honey - Allergic Conjunctivitis | Phase 4 | Withdrawn | Toyos Clinic | 2020-01-01 | 2020-10-09 | |
| Effects of Xiidra on Closed Eye Tear Film Leukocytes in Dry Eye Disease Lifitegrast - Ocular Discomfort, Ocular Inflammation | Phase 4 | Withdrawn | University of Alabama at Birmingham | 2019-01-01 | 2019-05-17 | |
| Repository Corticotropin Injection in Keratoconjunctivitis Sicca repository corticotropin injection - Keratoconjunctivitis Sicca | Phase 4 | Withdrawn | University of Alabama at Birmingham | 2018-11-01 | 2018-12-14 | |
| Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis azithromycin, ivermectin, albendazole - Trachoma, Lymphatic Filariasis | Phase 4 | Withdrawn | Emory University | 2014-02-01 | 2014-05-22 | |
| Hyaluronic Acid Gels for Lower Lid Retraction Hyaluronic acid, Saline - Ectropion | Phase 4 | Withdrawn | University of California, Los Angeles | 2013-02-01 | 2014-12-03 | |
| Comparison of CL Wear Between Two Allergy Drops epinastine HCL and olopatadine HCL - Allergic Conjunctivitis | Phase 4 | Withdrawn | Hom, Milton M., OD, FAAO | 25 | 2007-07-01 | 2010-10-07 |
| Azithromycin in Control of Trachoma II Azithromycin - Trachoma | Phase 4 | Withdrawn | University of California, San Francisco | 2005-06-01 | 2012-04-16 |
Trachoma (4) · Keratoconjunctivitis Sicca (3) · Conjunctivitis, Allergic (2) · Dry Eye Syndromes (2) · Communicable Diseases (1) · Ectropion (1) · Elephantiasis, Filarial (1) · Hypersensitivity (1) · Neglected Diseases (1)
Conjunctival Diseases (9) · Eye Diseases (9) · Corneal Diseases (7) · Bacterial Infections (4) · Bacterial Infections and Mycoses (4) · Chlamydia Infections (4) · Chlamydiaceae Infections (4) · Conjunctivitis, Bacterial (4) · Eye Infections (4) · Eye Infections, Bacterial (4) · Gram-Negative Bacterial Infections (4) · Infections (4) · Keratitis (3) · Keratoconjunctivitis (3)
Azithromycin (4) · Albendazole (1) · Hyaluronic Acid (1) · Ivermectin (1) · Olopatadine Hydrochloride (1) · Restylane (1) · Sodium Chloride (1) · epinastine (1) · lifitegrast (1)
Emory University (2) · University of Alabama at Birmingham (2) · University of California, San Francisco (2) · Hom, Milton M., OD, FAAO (1) · Toyos Clinic (1) · University of California, Los Angeles (1)
United States (4) · Democratic Republic of the Congo (1) · Mozambique (1)
Catherine Oldenburg, ScD, MPH (1) · Chandler R Dawson, MD (1) · Daniel B Rootman, MD, MSc (1) · Elodie Lebas, RN (1) · Huub C Gelderblom, MD, PhD, MPH (1) · Jason J Nichols, OD, MPH, PhD (1) · Julius Schachter, PhD (1) · Kelly Callahan, MPH (1) · Kelly K Nichols, OD MPH PhD (1) · Milton M Hom, OD FAAO (1) · Ricardo Thompson, PhD (1) · Thomas Lietman, MD (1)
5UG1EY030833 (1), R01AI048789 (1)